| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |